Risk factors of scalp itching for establishing scalp care in patients with hair loss undergoing chemotherapy

2021 Fiscal Year Final Research Report

• Project/Area Number: 19K10947
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 58060:Clinical nursing-related
• Research Institution: The University of Tokyo
• Principal Investigator: Tamai Nao 東京大学, 大学院医学系研究科(医学部), 特任准教授 (80636788)
• Co-Investigator(Kenkyū-buntansha): 峰松 健夫 東京大学, 大学院医学系研究科(医学部), 特任准教授 (00398752) ; 真田 弘美 東京大学, 大学院医学系研究科(医学部), 教授 (50143920)
• Project Period (FY): 2019-04-01 – 2022-03-31
• Keywords: 化学療法 / 脱毛

Outline of Final Research Achievements

This study aim was to explore risk factors of scalp itching and to evaluate appropriate scalp care in patients with hair loss undergoing chemotherapy. Secondary data analysis, basic experiments, and a case study was conducted. As the results, the skin becomes thinner and is prone to decreased transdermal epidermal water loss by chemotherapy administration. The skin became fragility by chemotherapy. Therefore, we provided another wig made of skin-friendly material including silk protein for the patients who used a medical wig and developed scalp itching and scalp disorders. In the patient, the itching was reduced the next day and followed by improvement of skin disorders. In other words, it is highly likely that itching can be suppressed by reducing external stimuli.

Free Research Field

がん看護学、スキンケア、可視化

Academic Significance and Societal Importance of the Research Achievements

化学療法中は頭皮が脆弱になり、痒みを生じるため、頭皮に直接触れるウィッグは、医療用かつネット部分の素材がシリコン製などの肌に優しい素材を使用したものを初期から勧める必要がある。それにより、患者の頭皮の痒みや皮膚障害を予防でき、快適な治療生活を支援できる可能性がある。